(La Jolla Institute for Allergy and Immunology) Researchers from the La Jolla Institute for Allergy & Immunology have joined forces with the Dana-Farber Cancer Institute and Washington University to investigate a potential new therapy for sickle cell disease. A drug called Lexisca,...
By swapping out a hydrogen atom for an isotope twice as heavy, researchers have increased the shelf life and detection ability of fluorescent probes that are essential to studying a variety of inflammatory diseases, including cancer and atherosclerosis.
Industrial parts distributor Applied Industrial Technologies Inc. said Tuesday its board of directors raised the quarterly dividend 13 percent to 17 cents.The company said the dividend is payable Aug. 31 to shareholders of record as of Aug. 16.Shares of Applied Industrial rose 9 cents to $26.05...
A team of ocean scientists has a plan to track the oil from the Deepwater Horizon spill, but so far they have no funding. Team leader Ira Leifer explains the proposed study. He says basic questions about the oil spill, such as where the oil is going, are not being answered.
In his 1984 book, Hackers: Heroes of the Computer Revolution, author Steven Levy profiled some of the personalities whose work brought PCs to the people, including Bill Gates and Steve Jobs. Levy discusses his book, recently reissued, and hacker ethics in the Internet age.
We have smart cars and smart phones, why not smart clothes? They might be coming soon. Materials scientist Yoel Fink describes his work developing fibers that take photos, listen and transmit sound. He says a shirt may one day monitor your health by tracking body sounds.
Each summer, horseshoe crabs (Limulus polyphemus) along the Atlantic shore crawl onto beaches to mate and lay eggs -- making now a good time for marine scientists like John Tanacredi to monitor population size. Science Friday visits a New York beach to catch a glimpse of the action.
An international team of physicists reexamined the radius of a proton, and found it to be 4 percent smaller than previously thought. Are they mistaken, or is something missing from the long-held theory of quantum electrodynamics? Physicist Brian Odom of Northwestern University discusses.
The Nobel Prize winner and former NIH director has received another presidential appointment: director of the National Cancer Institute. Ira Flatow and Varmus discuss the intersection of politics and science, the genetics of cancer and the process by which basic research becomes medicine.
Last December, e-mails written by climate scientists raised suspicion of scientific misconduct and conspiracy. International investigations have since exonerated the scientists of accusations of manipulating data. New York Times contributor Andrew Revkin explains what happened.
Waltham-based research firm Decision Resources reported today that the launch of nine emerging therapies will help to drive the prostate cancer drug market to more than double to $8.4 billion a year by 2019 in major markets.
NIH's Anthony S. Fauci to discuss early HIV infection and a novel target for HIV vaccine developmentJuly 20, 2010 7:34 am | by EurekAlert | News | Comments
(NIH/National Institute of Allergy and Infectious Diseases) In a plenary lecture at the 18th International AIDS conference in Vienna, Austria, Anthony S. Fauci, M.D., will present new insights on the early and complex pathogenic events that occur rapidly -- within hours to days --...
Xilinx is developing a 3D architecture for its FPGAs and Actel has been approached by SoC makers to use its flash-based FPGA as a layer in a 3D IC stack according to a recent article from Chip Design Magazine. Both approaches could radically alter the fundamental equation about the...
External infusion pumps are medical devices that deliver fluids, including nutrients and medications such as antibiotics, chemotherapy drugs, and pain relievers, into a patient?s body in controlled amounts.
The Southeast's first comprehensive medical device innovation center has been awarded a total of $2.6 million to build and equip a prototyping design and development facility that will accelerate the commercialization of next-generation medical devices and technology.